ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. C. 医薬保健学域; 医学類・薬学類・医薬科学類・保健学類
  2. c 10. 学術雑誌掲載論文(医・保健)
  3. 1. 査読済論文(医学・保健)

Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei murill: A survey of Japanese consumers with cancer

http://hdl.handle.net/2297/9504
http://hdl.handle.net/2297/9504
c95c7f4d-acd6-4862-a6ba-dd7c0a916c58
名前 / ファイル ライセンス アクション
ME-PR-LEE-32.pdf ME-PR-LEE-32.pdf (270.2 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2017-10-03
タイトル
タイトル Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei murill: A survey of Japanese consumers with cancer
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Talcott, James A.

× Talcott, James A.

WEKO 21250

Talcott, James A.

Search repository
Clark, Jack A.

× Clark, Jack A.

WEKO 21251

Clark, Jack A.

Search repository
Lee, Insu P.

× Lee, Insu P.

WEKO 21252

Lee, Insu P.

Search repository
提供者所属
内容記述タイプ Other
内容記述 金沢大学大学院医学系研究科補完代替医療
書誌情報 BMC Complementary and Alternative Medicine

巻 7, 発行日 2007-10-29
ISSN
収録物識別子タイプ ISSN
収録物識別子 1472-6882
NCID
収録物識別子タイプ NCID
収録物識別子 AA12034810
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 10.1186/1472-6882-7-32
抄録
内容記述タイプ Abstract
内容記述 Background: To survey cancer patients who consume an extract of the Basidiomycetes Agaricus blazei Murill mushroom (Sen-Sei-Ro) to measure their self-assessment of its effects and to develop an instrument for use in future randomized trials. Methods: We designed, translated and mailed a survey to 2,346 Japanese consumers of Sen-Sei-Ro self-designated as cancer patients. The survey assessed consumer demographics, cancer history, Sen-Sei-Ro consumption, and its perceived effects. We performed exploratory psychometric analyses to identify distinct, multi-item scales that could summarize perceptions of effects. Results: We received completed questionnaires from 782 (33%) of the sampled Sen-Sei-Ro consumers with a cancer history. Respondents represented a broad range of cancer patients familiar with Sen-Sei-Ro. Nearly all had begun consumption after their cancer diagnosis. These consumers expressed consistently positive views, though not extremely so, with more benefit reported for more abstract benefits such as emotional and physical well-being than relief of specific symptoms. We identified two conceptually and empirically distinct and internally consistent summary scales measuring Sen-Sei-Ro consumers' perceptions of its effects, Relief of Symptoms and Functional Well-being (Cronbach's alpha: Relief of Symptoms, α = .74; Functional Well-Being, α = .91). Conclusion: Respondents to our survey of Sen-Sei-Ro consumers with cancer reported favorable perceived effects from its use. Our instrument, when further validated, may be a useful outcome in trials assessing this and other complementary and alternative medicine (CAM) substances in cancer patients. © 2007 Talcott et al; licensee BioMed Central Ltd.
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
シリーズ
関連名称 32
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-28 01:09:05.942803
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3